Greenwich LifeSciences, Inc. (GLSI) Debt-to-equity % [USD] 2021 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Greenwich LifeSciences, Inc. quarterly Debt-to-equity history and growth rate from 2021 to 2024.
Greenwich LifeSciences, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 4.1 %, a 143% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	4.1	+2.41	+143%	Mar 31, 2024
Q4 2023	2.98	+1.49	+99.9%	Dec 31, 2023
Q3 2023	2.47	+1.08	+77.8%	Sep 30, 2023
Q2 2023	2.04	+0.61	+42.7%	Jun 30, 2023
Q1 2023	1.69	+0.02	+1.2%	Mar 31, 2023
Q4 2022	1.49	-0.41	-21.6%	Dec 31, 2022
Q3 2022	1.39	-1.07	-43.5%	Sep 30, 2022
Q2 2022	1.43	-2.94	-67.2%	Jun 30, 2022
Q1 2022	1.67			Mar 31, 2022
Q4 2021	1.9			Dec 31, 2021
Q3 2021	2.46			Sep 30, 2021
Q2 2021	4.37			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.